OKEP 12 Jun'15

a) Partial D2 agonism

b) Partial 5-HT1A agonism

c) 5-HT2A antagonism

d) All of the above

a) aripiprazole binding to three different receptors: D2, 5HT1A, 5HT2A

b) Aripiprazole binds to the D2 receptor with the same affinity than dopamine, but has a lower intrinsic efficacy, so the response it triggers is higher than dopamine.

c) As partial agonist at D2 receptors, it modulates neurotransmission in dopaminergic pathways

d) All true

a) Over-activation of dopaminergic neurotransmission in the mesocortical pathway.

b) Over-activation of dopaminergic neurotransmission in the mesolimbic pathway.

c) Over-activation of dopamine in the brain.

d) All of the above

a) ARIP MT

b) ARPIZOL

c) ASPRITO

d) TORIPNZ

a) 10mg,

b) 15mg

c) 20 mg

d) 30 mg

a) Fatigue

b) Diarrhea

c) Salivary Hypersecretion

d) Somnolence

e) All of the above

a) Bipolar Disorder

b) Depression

c) Anxiety

d) Schizophrenia

a) 30 Crs

b) 20 Crs

c) 127.5 Crs

d) 150 Crs